{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T15:58:11Z","timestamp":1720454291488},"reference-count":11,"publisher":"Walter de Gruyter GmbH","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Severe adverse events associated with varicella-zoster virus (VZV) vaccination are rare. The authors describe a 53-year-old woman with no known immunodeficiency who presented with diffuse pruritic rash 17 days after receiving the varicella virus vaccine live. She had a low level of white blood cells and received a diagnosis of thrombocytopenia with elevated aminotransferase levels. Punch biopsy demonstrated positive VZV immunostaining and viral culture positive for VZV. After treatment with acyclovir, her rash improved and her white blood cell and platelet counts returned to normal. Mild reactions to vaccines including localized rash are well recognized. Disseminated infections have been reported in patients with congenital and acquired immunodeficiency, but systemic postvaccination infections are rare in immunocompetent adults. This case highlights the importance of recognizing adverse events associated with vaccination.<\/jats:p>","DOI":"10.7556\/jaoa.2016.082","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T16:41:03Z","timestamp":1464021663000},"page":"402-405","source":"Crossref","is-referenced-by-count":2,"title":["Disseminated Varicella-Zoster Virus After Vaccination in an Immunocompetent Patient"],"prefix":"10.1515","volume":"116","author":[{"given":"Allison H.","family":"Scotch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elika","family":"Hoss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Orenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriane I.","family":"Budavari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"key":"2022022617281037911_j_jaoa.2016.082_ref_001","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J Infect Dis."},{"key":"2022022617281037911_j_jaoa.2016.082_ref_002","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1086\/522161","article-title":"Safety of varicella vaccine after licensure in the United States: experience from reports to the Vaccine Adverse Events Reporting System, 1995-2005.","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis."},{"issue":"12","key":"2022022617281037911_j_jaoa.2016.082_ref_003","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/infdis\/jir660","article-title":"Disseminated varicella infection caused by varicella vaccine strain in a child with low invariant natural killer T cells and diminished CD1d expression [published online October 31, 2011].","volume":"204","author":"Banovic","year":"2011","journal-title":"J Infect Dis."},{"issue":"7","key":"2022022617281037911_j_jaoa.2016.082_ref_004","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1086\/378503","article-title":"Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells [published online September 26, 2003].","volume":"188","author":"Levy","year":"2003","journal-title":"J Infect Dis."},{"issue":"2","key":"2022022617281037911_j_jaoa.2016.082_ref_005","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1542\/peds.108.2.e39","article-title":"Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child.","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics."},{"issue":"7","key":"2022022617281037911_j_jaoa.2016.082_ref_006","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/cid\/ciu970","article-title":"Disseminated, persistent, and fatal infection due to the vaccine strain of varicella-zoster virus in an adult following stem cell transplantation [published online December 1, 2014].","volume":"60","author":"Bhalla","year":"2015","journal-title":"Clin Infect Dis."},{"issue":"7","key":"2022022617281037911_j_jaoa.2016.082_ref_007","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.mayocp.2015.04.021","article-title":"Risk of herpes zoster and disseminated varicella zoster in patients taking immunosuppressant drugs at the time of zoster vaccination [published online June 4, 2015].","volume":"90","author":"Cheetham","year":"2015","journal-title":"Mayo Clin Proc."},{"issue":"7","key":"2022022617281037911_j_jaoa.2016.082_ref_008","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1086\/378504","article-title":"Varicella vaccine: rare serious problems-but the benefits still outweigh the risks [published online September 26, 2003].","volume":"188","author":"Gershon","year":"2003","journal-title":"J Infect Dis."},{"issue":"7-8","key":"2022022617281037911_j_jaoa.2016.082_ref_009","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0264-410X(00)00297-8","article-title":"The postmarketing safety profile of varicella vaccine.","volume":"19","author":"Sharrar","year":"2001","journal-title":"Vaccine."},{"issue":"3","key":"2022022617281037911_j_jaoa.2016.082_ref_010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajic.2010.06.027","article-title":"Vaccine-related varicella-zoster rash in a hospitalized immunocompetent patient [published online January 26, 2011].","volume":"39","author":"Bernstein","year":"2011","journal-title":"Am J Infect Control."},{"issue":"3","key":"2022022617281037911_j_jaoa.2016.082_ref_011","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2146\/ajhp080603","article-title":"Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: a review of the literature.","volume":"67","author":"Ward","year":"2010","journal-title":"Am J Health Syst Pharm."}],"container-title":["Journal of Osteopathic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2016.082\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2016.082\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T17:28:41Z","timestamp":1645896521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2016.082\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":11,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,1]]},"published-print":{"date-parts":[[2016,6,1]]}},"alternative-id":["10.7556\/jaoa.2016.082"],"URL":"https:\/\/doi.org\/10.7556\/jaoa.2016.082","relation":{},"ISSN":["2702-3648"],"issn-type":[{"value":"2702-3648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,1]]}}}